Goldman Sachs has downgraded MoonLake Immunotherapeutics (MLTX) to Sell, highlighting the failed VELA-2 trial endpoint and persistent approval risks for its key drug, sonelokimab, despite a competing firm's more bullish outlook.
Analysts at Stifel have raised their price target for Nurix Therapeutics (NRIX) to $35, maintaining a Buy rating ahead of anticipated 2026 clinical milestones for its lead asset, bexobrutinib. The move comes as Wells Fargo also adjusted its target, highlighting divergent near-term views but shared long-term optimism for the biotech firm.
Amphenol Corporation (NYSE: APH), a key player in electronic connectors, received concurrent price target increases from Seaport Research and Citi. While analysts highlight growth potential, the stock's post-earnings dip underscores a cautious market stance toward the company's traditionally conservative guidance.
Amid a quarter dominated by mega-cap tech and AI fervor, Pzena Investment Management's value-focused fund highlighted discount retailer Dollar General as a key performer, driven by strong earnings that propelled its stock.
Oppenheimer and Wells Fargo have raised price targets for Monolithic Power Systems (MPWR), highlighting robust demand from the automotive and artificial intelligence sectors as key growth drivers ahead of the company's quarterly results.
First Pacific Advisors' FPA Crescent Fund disclosed it sold its position in tech giant Microsoft in Q4 2025. The value-focused fund explained the move was driven by a search for greater upside in other AI-related investments, despite acknowledging Microsoft's strong fundamentals.
Investment firm Giverny Capital Asset Management reduced its stake in industrial manufacturer AMETEK in Q4 2025, highlighting a disciplined approach to valuation as markets remain captivated by AI narratives. The firm's portfolio underperformed major indices, pressured by its underweight stance in mega-cap technology.
Analysts at Piper Sandler have increased their price target for Permian Basin-focused producer Diamondback Energy (FANG) to $218, maintaining an Overweight rating. The move comes as the firm anticipates solid Q4 results for gas-focused companies, while oil producers navigate a tougher pricing environment.
Wells Fargo lowered its price target on UnitedHealth Group (UNH) following its Q4 report and a disappointing Medicare rate proposal from regulators, highlighting pressures on the healthcare giant's key growth engine.
While recent market surges have lifted several names, discerning investors must separate fleeting hype from durable growth. We analyze two companies capitalizing on structural shifts and one whose valuation appears dangerously disconnected from fundamentals.
French IT giant Capgemini initiates the sale of its U.S. federal subsidiary, Capgemini Government Solutions, attributing the move to restrictive oversight rules for classified contracts and a desire for strategic focus.
UK retail property specialist NewRiver REIT signals a resilient operational performance in its third quarter, driven by sustained consumer spending and strategic capital recycling, while navigating business rate changes.
A Nevada court has issued a temporary restraining order against prediction market platform Polymarket, blocking it from offering event contracts to state residents. The ruling marks a significant early victory for state gaming regulators amid a national debate over who should oversee these fast-growing markets.
Florida Attorney General Pam Bondi forcefully rebutted First Amendment criticisms following the arrests of ex-CNN anchor Don Lemon and several activists at a St. Paul church, framing the incident as a dangerous disruption that terrorized worshippers and vowing full prosecution.
Texas Instruments (TXN) reported a 70% year-over-year surge in data center orders, prompting the company to break out the segment separately. Management forecasts the first sequential revenue growth since 2008, citing improving industrial trends and AI-related infrastructure spending.
A federal judge has removed the death penalty as an option for Luigi Mangione, accused of assassinating a top health insurance executive in New York. The ruling narrows the federal case while state murder charges proceed.
JPMorgan raises Edison International's price target to $66, citing model updates ahead of earnings. The utility giant, noted for its sustainable high-yield dividend, continues to benefit from California's electrification trends and regulated investment framework.
Bank of America raises its price target on Chevron (CVX) to $188, maintaining a Buy rating, as geopolitical tensions and a planned ramp-up of Venezuelan crude exports bolster the energy giant's near-term outlook.
Realtor.com ranks the Florida Keys among the nation's top luxury markets, where strict development limits and finite land create a high-stakes arena for elite buyers seeking a unique legacy, not just a second home.
Following a turbulent 2025, Bitwise Chief Investment Officer Matt Hougan anticipates a period of consolidation for Bitcoin, driven by growing institutional adoption and nascent central bank interest, which he believes lays the groundwork for an unprecedented long-term valuation.
